Watch this CME-certified on-demand Webcast of a CCO symposium at AASLD 2019 to gain expert perspectives on the evolving treatment landscape for HCC, with a focus on first-line and second-line systemic therapy for advanced/unresectable disease.
Download this slideset for expert perspectives on the optimal use of locoregional therapies for HCC, as well as a look at key factors in transitioning to systemic therapy.
Download this slideset for expert perspectives on the optimal use of systemic therapy in the first-line setting for patients with advanced HCC.
Download this slideset for expert perspectives on sequencing systemic therapy for patients with advanced HCC who have failed an initial systemic regimen.
Download this slideset for expert perspectives on current best practices and emerging strategies in immune checkpoint inhibitor therapy for patients with advanced HCC.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.